Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy

Velja Mijatovic*, Sebastiaan Veersema, Mark Hans Emanuel, Roel Schats, Peter G.A. Hompes

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

60 Citations (Scopus)

Abstract

Objective: To investigate the success rate of proximal tubal occlusion with Essure devices in subfertile women with hydrosalpinges, and to observe the results of subsequent treatment with IVF. Design: Prospective, single-arm, clinical study. Setting: University hospital and teaching hospital. Patient(s): Ten women with uni- or bilateral hydrosalpinges prior to IVF. In all patients laparoscopy was felt to be contraindicated. Intervention(s): Hysteroscopic placement of Essure devices in an office setting. Main Outcome Measure(s): Placement rate, successful proximal tubal occlusion, and pregnancy rate after IVF. Result(s): All patients had successful placement of the Essure devices without any complications. Proximal tubal occlusion was confirmed by hysterosalpingography in 9 out of 10 patients. A 40% ongoing pregnancy rate was achieved with 20% life births after one IVF cycle and/or frozen embryo transfer. Conclusion(s): Proximal occlusion of hydrosalpinges with Essure devices before IVF is a successful treatment for patients with a contraindication for salpingectomy.

Original languageEnglish
Pages (from-to)1338-1342
Number of pages5
JournalFertility and Sterility
Volume93
Issue number4
DOIs
Publication statusPublished - 1 Mar 2010

Keywords

  • Essure hysteroscopic tubal occlusion
  • hydrosalpinges
  • IVF-ET

Fingerprint

Dive into the research topics of 'Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy'. Together they form a unique fingerprint.

Cite this